세계의 신경과학 시장 : 유형별, 최종사용자별 예측(2025-2030년)

The Neuroscience Market was valued at USD 13.77 billion in 2023, expected to reach USD 15.11 billion in 2024, and is projected to grow at a CAGR of 10.34%, to USD 27.42 billion by 2030.

The scope of neuroscience as a market research domain encompasses the study and application of biological and cognitive sciences to understand and enhance human brain function. This field's necessity arises from growing demand for solutions to treat neurological disorders, mental health challenges, and degenerative diseases. Applications span pharmaceuticals, biotechnology, cognitive neuroscience, and neurotechnology, with end-use sectors including healthcare, education, and defense. Market growth is influenced by factors such as technological advancements in brain imaging, increased funding for neurological research, and a heightened focus on mental health awareness. The influx of artificial intelligence and machine learning technologies presents significant opportunities for innovation, such as personalized treatment plans and predictive analytics in mental health care. Furthermore, the expansion of telehealth services amid the COVID-19 pandemic has accelerated integration of neuroscience-driven applications in remote care settings. However, challenges persist, including high R&D costs, regulatory hurdles, and ethical considerations surrounding neurotechnological advancements. Additionally, the market is fragmented, with a few dominant players and numerous niche developers, adding competitive pressure. Areas ripe for innovation include developing non-invasive neurostimulation techniques, enhancing brain-computer interface technologies, and exploring the therapeutic potential of psychedelic substances and their neural impact. Business growth can be further bolstered by leveraging collaborations with universities and research institutions, fostering interdisciplinary research, and prioritizing patient-centric approaches in product development. As the market is inherently dynamic and rapidly evolving, staying ahead requires companies to remain vigilant of emerging trends and regulatory changes. The nature of the neuroscience market is therefore characterized by high innovation potential, tempered by challenges in monetization and ethical deployment, necessitating a strategic blend of research focus and market agility.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neuroscience Market

The Neuroscience Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of neurological disorders worldwide
  • Rise in drug discovery and development for neurological conditions
  • Increasing use of neuroscience to enhance brain health and cognitive functions
• Market Restraints
  • High cost associated with neuroscience research
• Market Opportunities
  • Emerging use of neuroscience in the development of personalized medicine
  • Favorable funding landscape for neuroscience research
• Market Challenges
  • Functional limitations pertaining to the use of neurotechnologies

Porter's Five Forces: A Strategic Tool for Navigating the Neuroscience Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neuroscience Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neuroscience Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neuroscience Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neuroscience Market

A detailed market share analysis in the Neuroscience Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neuroscience Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neuroscience Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neuroscience Market

A strategic analysis of the Neuroscience Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neuroscience Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bayer AG, Bio-Rad Laboratories, Inc., Brain Products GmbH, Compumedics Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Gilson, Inc., GL Sciences Inc., Hitachi, Ltd., Illumina, Inc., JASCO Corporation, Merck KGaA, Metrohm AG, Natus Medical Incorporated, Novasep Holding SAS, PerkinElmer Inc., Pfizer Inc., Promega Corporation, QIAGEN GmbH, Restek Corporation, Shimadzu Corporation, Siemens AG, Thermo Fisher Scientific Inc., Waters Corporation, and YMC Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Neuroscience Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Diagnostic Solution, Drug Therapy, and Non-drug Therapy. The Diagnostic Solution is further studied across Molecular and Non-molecular. The Molecular is further studied across Immunoassay, Instruments, Kits & Consumables, Liquid Chromatography, PCR, Sequencing, and Software. The Non-molecular is further studied across Brainstem auditory evoked potential, Electroencephalography, and Imaging. The Drug Therapy is further studied across Neurological disorders and Neuropsychiatric disorders. The Neurological disorders is further studied across Alzheimer's disease, Epilepsy, Huntington's disease, Multiple sclerosis, Parkinson's disease, and Vascular dementia. The Neuropsychiatric disorders is further studied across Anxiety, Attention deficit, Autism spectrum, Insomnia, Mood disorder, and Substance abuse. The Non-drug Therapy is further studied across Behavioral Therapy and Digital Health Services. The Behavioral Therapy is further studied across Animal-assisted, Home-based, Inpatient, and Outpatient.
• Based on End-User, market is studied across Diagnostic Laboratories, Hospitals, and Research & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of neurological disorders worldwide
    • 5.1.1.2. Rise in drug discovery and development for neurological conditions
    • 5.1.1.3. Increasing use of neuroscience to enhance brain health and cognitive functions
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with neuroscience research
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging use of neuroscience in the development of personalized medicine
    • 5.1.3.2. Favorable funding landscape for neuroscience research
  • 5.1.4. Challenges
    • 5.1.4.1. Functional limitations pertaining to the use of neurotechnologies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neuroscience Market, by Type

• 6.1. Introduction
• 6.2. Diagnostic Solution
  • 6.2.1. Molecular
    • 6.2.1.1. Immunoassay
    • 6.2.1.2. Instruments
    • 6.2.1.3. Kits & Consumables
    • 6.2.1.4. Liquid Chromatography
    • 6.2.1.5. PCR
    • 6.2.1.6. Sequencing
    • 6.2.1.7. Software
  • 6.2.2. Non-molecular
    • 6.2.2.1. Brainstem auditory evoked potential
    • 6.2.2.2. Electroencephalography
    • 6.2.2.3. Imaging
• 6.3. Drug Therapy
  • 6.3.1. Neurological disorders
    • 6.3.1.1. Alzheimer's disease
    • 6.3.1.2. Epilepsy
    • 6.3.1.3. Huntington's disease
    • 6.3.1.4. Multiple sclerosis
    • 6.3.1.5. Parkinson's disease
    • 6.3.1.6. Vascular dementia
  • 6.3.2. Neuropsychiatric disorders
    • 6.3.2.1. Anxiety
    • 6.3.2.2. Attention deficit
    • 6.3.2.3. Autism spectrum
    • 6.3.2.4. Insomnia
    • 6.3.2.5. Mood disorder
    • 6.3.2.6. Substance abuse
• 6.4. Non-drug Therapy
  • 6.4.1. Behavioral Therapy
    • 6.4.1.1. Animal-assisted
    • 6.4.1.2. Home-based
    • 6.4.1.3. Inpatient
    • 6.4.1.4. Outpatient
  • 6.4.2. Digital Health Services

7. Neuroscience Market, by End-User

• 7.1. Introduction
• 7.2. Diagnostic Laboratories
• 7.3. Hospitals
• 7.4. Research & Academic Institutes

8. Americas Neuroscience Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Neuroscience Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Neuroscience Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Bayer AG
• 3. Bio-Rad Laboratories, Inc.
• 4. Brain Products GmbH
• 5. Compumedics Limited
• 6. Eli Lilly and Company
• 7. F. Hoffmann-La Roche Ltd.
• 8. Gilson, Inc.
• 9. GL Sciences Inc.
• 10. Hitachi, Ltd.
• 11. Illumina, Inc.
• 12. JASCO Corporation
• 13. Merck KGaA
• 14. Metrohm AG
• 15. Natus Medical Incorporated
• 16. Novasep Holding SAS
• 17. PerkinElmer Inc.
• 18. Pfizer Inc.
• 19. Promega Corporation
• 20. QIAGEN GmbH
• 21. Restek Corporation
• 22. Shimadzu Corporation
• 23. Siemens AG
• 24. Thermo Fisher Scientific Inc.
• 25. Waters Corporation
• 26. YMC Co., Ltd.